Medtronic Plc. · NYSE:MDT

Medtronic — Fact Sheet (2023)

2 slides from Medtronic's fact sheet, 2023

1. Slide 1: TAVI clinical implications from TCT 2023: Evolut in low risk patients

   ™ TAVI †1 Clinical implications from late-breaking evidence presented at TCT 2023: In younger, low risk patients, the Evolut platform is the 1 25% All-cause mortality or disabling stroke † 4 years: SAVR 20% 3 years: 14.1% 2 years: 15% 1 year: 10 % in Kaplan- 10% % 10.7% 10.7% Meier rates % 5% 7 4% o

2. Slide 2: medtronic.eu medtronic.com

   1 Europe medtronic.eu medtronic.com

Medtronic — Fact Sheet (2023) on 6ix